Pubfacts - Scientific Publication Data
  • Categories
  • Journals
  • ->
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice.

Authors:
Mélanie Demers Benoit Ho-Tin-Noé Daphne Schatzberg Janie J Yang Denisa D Wagner

Cancer Res 2011 Mar 6;71(5):1540-9. Epub 2011 Jan 6.

The Immune Disease Institute, Boston, Massachusetts 02115, USA.

Platelets contribute to homeostasis of the tumor vasculature by helping prevent hemorrhage. Thus, we hypothesized that inducing thrombocytopenia would increase tumor vascular leakiness and facilitate the effective delivery of chemotherapeutic agents to tumors. In a mammary carcinoma murine model, platelet depletion induced bleeding specifically at the tumor site, favoring the accumulation of fluorescently labeled microspheres only in the tumor. Moreover, induction of thrombocytopenia in tumor-bearing mice before injection of paclitaxel increased its intratumoral accumulation and reduced growth of both slow- and fast-growing tumors, compared with mice with normal platelet counts that were treated only with paclitaxel. Histologic analysis confirmed the expectation of an increase in tumor apoptosis and a reduction in tumor proliferation in thrombocytopenic mice receiving chemotherapy. No increased toxicity was seen in other organs or blood cells. Taken together, our results indicate that low platelet count selectively induces leakiness of tumor vessels and favors the delivery of chemotherapy to tumor sites, enhancing its tumoricidal effects.

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078642PMC
March 2011

Publication Analysis

Top Keywords

tumor
8
increase tumor
8
thrombocytopenic mice
8
proliferation thrombocytopenic
4
favoring accumulation
4
indicate low
4
site favoring
4
accumulation fluorescently
4
labeled microspheres
4
microspheres tumor
4
paclitaxel histologic
4
fluorescently labeled
4
cells indicate
4
tumor site
4
bleeding tumor
4
murine model
4
model platelet
4
count selectively
4
carcinoma murine
4
tumor proliferation
4

Altmetric Statistics


Show full details
1 Total Shares
1 Citations

Similar Publications

Follistatin-like 1 deficiency impairs T cell development to promote lung metastasis of triple negative breast cancer.

Authors:
Jie Ma Ying Yang Lulu Wang Xiaowei Jia Tao Lu Yiyan Zeng Li Liu Yan Gao

Aging (Albany NY) 2021 Feb 26;13. Epub 2021 Feb 26.

Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Human Anatomy, School of Basic Medical Sciences, Capital Medical University, Beijing, China.

Our study aims to detect the underlying mechanism of the suppressive effect of Follistatin-like 1 (FSTL1) on lung metastasis of triple negative breast cancer (TNBC). We found that FSTL1 had no effect on the proliferation and metastasis of 4T1 cells in , while in the tumor-bearing Fstl1 heterozygous () mice, the number of anti-tumor T lymphocytes in the lung was significantly reduced with the increase in lung metastasis. Impaired development of T cells can cause dysfunction of adaptive immune system, which promotes cancer metastasis. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2.

Authors:
Danesh Hassani Mohammad Mehdi Amiri Mehdi Mohammadi Parisa Yousefi Mohammad Ali Judaki Maryam Mobini Forough Golsaz-Shirazi Mahmood Jeddi-Tehrani Fazel Shokri

Curr Res Transl Med 2021 Feb 24;69(2):103277. Epub 2021 Feb 24.

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Electronic address:

Background: The human epidermal growth factor receptor (HER/ErbB) family-targeted therapies result in a significant improvement in cancer immunotherapy. Monoclonal antibodies (MAb) against HER2 demonstrated a survival benefit for patients; however, drug resistance unavoidably occurs due to the overexpression of HER3, which leads to treatment failure. Effective inhibition of HER3 besides HER2 is thought to be required to overcome resistance and enhance therapeutic efficacy. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation.

Authors:
Zhiyang Wu Guotao Lu Luyao Zhang Lu Ke Chenchen Yuan Nan Ma Xianqiang Yu Xi Guo Wei Zhao Yingjie Wang Sanyuan Hu Dawei Wu Weiqin Li

Int Immunopharmacol 2021 Feb 24;94:107486. Epub 2021 Feb 24.

Department of Critical Care Medicine, PLA Key Laboratory of Emergency and Critical Care Research, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China. Electronic address:

Background: Docosahexaenoic acid-derived protectin D1 (PD1) was identified critical in the resolution of inflammation in vivo, where it modulates the innate immune response and stimulates resolution. Acute pancreatitis (AP) is characterized by local pancreatic inflammation with mild forms whereas systemic inflammation with severe forms. Herein we investigate the impact of PD1 in murine models of pancreatitis. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Glutathionylation-dependent proteasomal degradation of wide-spectrum mutant p53 proteins by engineered zeolitic imidazolate framework-8.

Authors:
Yunjiao Zhang Xiaowan Huang Liansheng Wang Cong Cao Hao Zhang Pengfei Wei He Ding Yang Song Ziying Chen Jieying Qian Suqin Zhong Zefeng Liu Meimei Wang Wenbin Zhang Wenwei Jiang Jie Zeng Guangyu Yao Long-Ping Wen

Biomaterials 2021 Feb 14;271:120720. Epub 2021 Feb 14.

Department of Cardiology, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, Guangzhou, 510080, China. Electronic address:

Point mutations within the DNA-binding domain of the TP53 gene occur in a significant percentage of human cancer, leading to cellular accumulation of highly stabilized mutant p53 proteins (mutp53) with tumor-promoting properties. Depletion of mutp53, through inducing either autophagic or proteasomal degradation, is an attractive strategy for the therapy of p53-mutated cancer, but the currently-known degradation inducers, almost exclusively small molecules, are inadequate. Here we show that pH-responsive zeolitic imidazolate framework-8 (ZIF-8) offers a novel solution to mutp53 degradation. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid Ga-DOTATOC PET/MRI.

Authors:
Nils Martin Bruckmann Christoph Rischpler Julian Kirchner Lale Umutlu Ken Herrmann Marc Ingenwerth Sarah Theurer Harald Lahner Gerald Antoch Lino M Sawicki

Eur J Radiol 2021 Feb 19;137:109588. Epub 2021 Feb 19.

University Dusseldorf, Medical Faculty, Department of Diagnostic and Interventional Radiology, D-40225 Dusseldorf, Germany.

Objectives: To investigate a correlation between Ga-DOTATOC PET/MR imaging parameters such as arterial and venous contrast enhancement, diffusion restriction, and maximum standardized uptake value (SUVmax) with histopathological tumor grading in patients with neuroendocrine neoplasms (NEN).

Material And Methods: A total of 26 patients with newly diagnosed, therapy-naive neuroendocrine neoplasms (NEN) were enrolled in this prospective study and underwent Ga-DOTATOC PET/MRI. Images were evaluated regarding NEN lesion number and location, predominant tumor signal intensity on precontrast T1w and T2w images and on postcontrast arterial and portal venous phase T1w images, apparent diffusion coefficient (ADC) and SUVmax. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
Get 20% Off Journals at LWW.com
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap